PTEN-L
|
Triple Negative Breast Cancer
|
PTEN-L
|
Triple Negative Breast Cancer
|
RG7440 Sensitive: C2 – Inclusion Criteria
|
RG7440 Sensitive: C2 – Inclusion Criteria
|
PTEN-L
|
Endometrial Cancer
|
PTEN-L
|
Endometrial Cancer
|
cobimetinib + RG7440 Sensitive: C3 – Early Trials
|
cobimetinib + RG7440 Sensitive: C3 – Early Trials
|
PTEN-L
|
Ovarian Cancer
|
PTEN-L
|
Ovarian Cancer
|
cobimetinib + RG7440 Sensitive: C3 – Early Trials
|
cobimetinib + RG7440 Sensitive: C3 – Early Trials
|